secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2024-11-08T23:59:59+00:00
Accession:  0001213900-24-095934
Event type: debt
Sentiment:  neutral
Materiality: 0.10
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne terminates loan agreement with Growth Opportunity Funding effective Nov 7, 2024
--------------------------------------------------------------------------------

- NeuroOne and Growth Opportunity Funding, LLC mutually terminated the Loan and Security Agreement dated August 2, 2024 on November 7, 2024.
- As of termination date, the Company had no loan balance outstanding under the agreement.
- The original Loan Agreement terms were disclosed in the Company's 8-K filed August 7, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390024095934/0001213900-24-095934-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390024095934/ea0220503-8k_neuro.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-095934

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer